Rege Nephro Co
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options
$10.6MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options
Pitching BA7 Venture Capital CORP? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room